For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220726:nRSZ6740Ta&default-theme=true
RNS Number : 6740T Workspace Group PLC 26 July 2022
26 July 2022
WORKSPACE GROUP PLC
WORKSPACE(®) ANNOUNCES DISPOSAL OF NEWBURY MEDICAL CENTRE
Workspace Group PLC ('Workspace'), London's leading provider of flexible
offices, is pleased to announce the simultaneous exchange and completion on
the disposal of a medical centre in Newbury, an asset from the McKay portfolio
acquired in May 2022, for a total of £7.25m. The sale of the property is at
a premium of £1.15m to the March 2022 valuation.
Graham Clemett, Chief Executive Officer of Workspace, commented:
"We are pleased to have completed on this first sale from the identified
non-core assets in the McKay portfolio. We continue to progress with our
disposal programme, targeting completion by December 2022, with the proceeds
expected to significantly reduce our LTV and increase the proportion of
fixed-rate debt."
- ENDS -
For media and investor enquiries, please contact:
Workspace Group PLC
Kate Annakin, Interim Investor Relations
Manager
020 7138 3300
FGS Global
Chris Ryall
020 7251 3801
Guy Lamming
Notes to Editors
About Workspace Group PLC:
Established in 1987 and listed on the London Stock Exchange since 1993. We are
home to
thousands of businesses, including fast growing and established brands across
a wide range of sectors.
Workspace is geared towards helping businesses perform at their very best. We
provide inspiring, flexible work spaces in dynamic London locations.
Workspace (WKP) is a FTSE 250 listed Real Estate Investment Trust (REIT) and a
member of the European Public Real Estate Association (EPRA).
Workspace® is a registered trademark of Workspace Group Plc, London, UK.
LEI: 2138003GUZRFIN3UT430
For more information on Workspace, please visit www.workspace.co.uk
(http://www.workspace.co.uk)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DISBKPBBABKDOOB